Targeted Complement Inhibition with Homodimeric Minimal Factor H During Porcine Normothermic Machine Perfusion Attenuates Renal Ischemia-Reperfusion Injury
Year: 2026
Type: article
Abstract: Background: The alternative pathway (AP) of complement activation is a key driver in the pathogenesis of ischaemia-reperfusion injury (IRI). Factor H (FH) acts as the principal regulator of the AP. This study evaluates the efficacy of a novel homodimeric minimal FH (HDM-FH) construct (previously shown to control the AP in several mouse models) within a high-fidelity, ex-vivo human-relevant model of renal injury. Methods: In a randomised study, 5 mg of HDM-FH was administered during 6-hour autologous whole blood-based normothermic machine perfusion (NMP) of porcine kidney pairs recovered following circulatory death. Renal physiology, markers of complement activation (soluble (s)C5b-9, tissue Bb, and C1q deposits), immune cell infiltration (neutrophils, macrophages, and T-cells), glycocalyx shedding, and markers of cell death were assessed and compared against controls. Results: HDM-FH administration resulted in no adverse effects on renal physiology. Treatment significantly reduced complement activation, evidenced by decreased sC5b-9 in perfusate (p=.048) and urine (p=.031), as well as reduced tissue deposits of Bb (p=.009) and intriguingly, C1q (p=.005). This inhibition correlated with a significant reduction in immune cell infiltration, including neutrophils (p=.015), macrophages (p=.021), and T-cells (p=.04). Furthermore, downstream indicators of IRI were improved, with attenuated glycocalyx shedding (p=.028) and reduced cell death (p=.001) at the conclusion of NMP. Conclusions: These findings demonstrate that HDM-FH effectively controls complement activation during IRI in a human-relevant model. By blocking the immunopathological cascade, localized real-time complement inhibition provides significant downstream benefits in reducing immune infiltration and cellular injury. Therefore, HDM-FH holds therapeutic potential for mitigating complement-mediated injury following transplantation.
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7234051665
